A treatment for childhood autism will soon be available.
Small clinical trials have shown that boys with autism exhibit improvements in speech and social skills when given suramin.
Small clinical trials have shown that boys with autism exhibit improvements in speech and social skills when given suramin.
Currently, there are no medications approved by the U.S. Food and Drug Administration (FDA) to treat the primary symptoms of autism spectrum disorder (ASD).
However, new findings published in the journal Annals of Neurologics Clinical and Translational open the door to new treatment options for children with ASD.
![]() |
| New research opens a door of hope for many parents of children with autism. |
In a phase 1/2 clinical trial at the University of San Diego School of Medicine (UCSD), researchers evaluated the effects of a drug called suramin, which is used in children with ASD.
Ten boys with autism, aged 5 to 14, participated in the treatment study. Five of them received suramin, and the other five received a placebo.
Observations from 5 children using suramin showed significant improvements in language and behavior, with no serious side effects reported.
Dr. Robert Naviaux, lead author and professor of medicine, pediatrics and pathology at UCSD, told Healthline: "We didn't expect to see statistically significant results in the primary behavior of all five children. However, we did find that the suramin group averaged a 1.6-point improvement in their ADOS autism diagnosis scores after six weeks, while the placebo group showed no change."
He added: "Autism spectrum disorder is defined as having an ADOS score from 7 to 10, with 10 being the highest. The children in the study had an average ADOS score of 8.6. After 6 weeks, the average was 7.0."
Among the children who used suramin, the study authors found changes in language, social communication, repetitive behaviors, coping skills, calmness, and concentration.
For example, two nonverbal boys were treated with the medication and spoke their first full sentences about a week after injection. And these effects diminished after a few weeks, suggesting that more doses may be needed.
For these findings to be safely replicated, larger follow-up studies are needed because experts believe that the signs of ASD vary among children and often overlap, making it difficult to identify the cause and treatment.
Therefore, to assess the effects of multiple suramin doses over a longer period, Naviaux plans to conduct larger follow-up studies.
He said, "We'll have to do the next test with 40 to 60 children at a few different locations. It will be a safety and efficacy study. We'll look at 40 to 60 children and ask, what are three doses of suramin given over a three-month period that are safe and effective in treating the main symptoms of autism?"
In the long term, he hopes this research can help develop safe and effective treatment strategies, not only for autism but also for many other health conditions.
He said: "What we learn from autism also gives us insights into deep biology and complex chronic diseases, such as chronic fatigue syndrome, post-traumatic stress disorder, depressive disorders, and many more."
According to VOV
| RELATED NEWS |
|---|
